Merck

Chutes & Ladders-Scholefield out as Merck & Co. digital head

2 days ago   |   Fierce Biotech

Merck & Co. digital head Scholefield bolts for Marriott; Endo replaces CEO Campanelli; BMS vet Quigley joins Gilead.
Read more ...

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

3 days ago   |   Xconomy

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin...
Read more ...

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution's IPO & More

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution's IPO & More

10 days ago   |   Xconomy

Drugs typically go through three phases of clinical testing to support an application for FDA approval. It's easy to overlook Phase 4, which takes place after a drug reaches...
Read more ...

Two Big Pharma Alliances End in Nixed Deals. Here's What Happened

Two Big Pharma Alliances End in Nixed Deals. Here's What Happened

12 days ago   |   Xconomy

Pfizer and Merck are each cutting ties with a smaller clinical-stage biotech after experimental drugs being developed under separate alliances fell short in human testing...
Read more ...

Trials flops see Pfizer cut GylcoMimetics pact, Merck ax KalVista research deal

13 days ago   |   Fierce Biotech

Two Big Pharmas have decided to walk away from two small biotech deals after disappointing trial results: Pfizer from GlycoMimetics and Merck from KalVista Pharmaceuticals.
Read more ...

Bio Roundup: POTUS on Prices, a16z's Fund, Aimmune's Approval & More

Bio Roundup: POTUS on Prices, a16z's Fund, Aimmune's Approval & More

17 days ago   |   Xconomy

The president's State of the Union address was wide-ranging, as they tend to be, but those who tuned in heard mention of two hot health policy topics: price transparency and...
Read more ...

Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate

Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate

18 days ago   |   Xconomy

Last week the FDA approved an Aimmune Therapeutics drug for children with peanut allergies , the first oral immunotherapy for a food allergy to get the agency's nod. On...
Read more ...

Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff

Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff

18 days ago   |   Xconomy

Merck is corralling products representing $6.5 billion in sales and spinning them off into a separate company , a strategic bet that focusing the remaining business on...
Read more ...

Regional Account Manager - CA - Merck KGaA - San Diego, CA

20 days ago   |   San Diego Biotechnology   |   7 articles

4+ years of commercial sales experience in the biotech industry. Working knowledge of pharmaceutical and biotech drug production processes/unit operations.From Merck KGaA...
Read more ...

Bio Roundup: Mammoth Moves, Black Diamond's Pop, Ohana's Debut & More

Bio Roundup: Mammoth Moves, Black Diamond's Pop, Ohana's Debut & More

24 days ago   |   Xconomy

If this week is any indication, the steady march of life science companies to Wall Street will continue in 2020. Black Diamond Therapeutics is leading the way, having raised...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

IAmScience George Stewart

IAmScience George Stewart

By Becca Wolf | Bond LSC Medical bacteriologist, George Stewart has had a few stops along the way before he got to Bond LSC in 2004. Having done schooling and research at... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...